deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT03357653

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1 (BEST-IgAN-1)

A Randomized, Double Blinded, Placebo-controlled, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Losartan in Early Immunoglobulin A Nephropathy (IgAN) Patients

Sponsor: Ajou University School of Medicine

Updated 7 times since 2017 Last updated: Nov 28, 2017 Started: Jan 30, 2018 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03357653, this PHASE3 trial focuses on Glomerulonephritis, Immunoglobulin A (IgA) and remains ongoing. Sponsored by Ajou University School of Medicine, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotNot Yet Recruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotNot Yet Recruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — Mar 2022 [monthly]

    Not Yet Recruiting PHASE3

  5. Feb 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

Show 2 earlier versions
  1. Jun 2018 — Feb 2020 [monthly]

    Not Yet Recruiting PHASE3

  2. Dec 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ajou University School of Medicine
  • Chonbuk National University Hospital
  • Chonnam National University Hospital
  • Eulji General Hospital
  • Ewha Womans University
  • Gangnam Severance Hospital
  • Hallym University Medical Center
  • Kangdong Sacred Heart Hospital
  • Korea University Guro Hospital
  • Kyung Hee University Hospital at Gangdong
  • Kyungpook National University Hospital
  • National Health Insurance Service Ilsan Hospital
  • Pusan National University Yangsan Hospital
  • SMG-SNU Boramae Medical Center
  • Seoul National University Bundang Hospital
  • Seoul National University Hospital
  • Severance Hospital
  • The Catholic University of Korea
Data source: Ewha Womans University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.